Endoglin: a critical mediator of cardiovascular health

References

• McAllisterKAGroggKMJohnsonDWEndoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemor-rhagic telangiectasia type 1Nat Genet1994843453517894484
   PubMed Web of Science ®Google Scholar
• LiDYSorensenLKBrookeBSDefective angiogenesis in mice lacking endoglinScience199928454191534153710348742
   PubMed Web of Science ®Google Scholar
• ConleyBASmithJDGuerrero-EsteoMBernabeuCVaryCPEndoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaquesAtherosclerosis2000153232333511164421
   PubMed Web of Science ®Google Scholar
• BotellaLMSanchez-ElsnerTSanz-RodriguezFTranscriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injuryBlood2002100124001401012433697
   PubMed Web of Science ®Google Scholar
• LiCGuoBBernabeuCKumarSAngiogenesis in breast cancer: the role of transforming growth factor beta and CD105Microsc Res Tech200152443744911170303
   PubMed Web of Science ®Google Scholar
• KapurNKWilsonSYunisAAReduced endoglin activity limits cardiac fibrosis and improves survival in heart failureCirculation2012125222728273822592898
   PubMed Web of Science ®Google Scholar
• van LaakeLWvan den DriescheSPostSEndoglin has a crucial role in blood cell-mediated vascular repairCirculation2006114212288229717088457
   PubMed Web of Science ®Google Scholar
• BernabeuCConleyBAVaryCPNovel biochemical pathways of endoglin in vascular cell physiologyJ Cell Biochem200710261375138817975795
   PubMed Web of Science ®Google Scholar
• CheifetzSBellonTCalesCEndoglin is a component of the transforming growth factor-beta receptor system in human endothelial cellsJ Biol Chem19922672719027190301326540
   PubMed Web of Science ®Google Scholar
• BarbaraNPWranaJLLetarteMEndoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamilyJ Biol Chem199927425845949872992
   PubMed Web of Science ®Google Scholar
• AltAMiguel-RomeroLDonderisJStructural and functional insights into endoglin ligand recognition and bindingPLoS One201272e2994822347366
   PubMed Web of Science ®Google Scholar
• CastonguayRWernerEDMatthewsRGSoluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthJ Biol Chem201128634300343004621737454
   PubMed Web of Science ®Google Scholar
• GougosALetarteMIdentification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell lineJ Immunol19881416192519333262644
   PubMed Web of Science ®Google Scholar
• GougosALetarteMPrimary structure of endoglin, an RGD-containing glycoprotein of human endothelial cellsJ Biol Chem199026515836183641692830
   PubMed Web of Science ®Google Scholar
• JovineLQiHWilliamsZLitscherEWassarmanPMThe ZP domain is a conserved module for polymerization of extracellular proteinsNat Cell Biol20024645746112021773
   PubMed Web of Science ®Google Scholar
• RossiESanz-RodriguezFElenoNEndothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigrationBlood2013121240341523074273
   PubMed Web of Science ®Google Scholar
• VenkateshaSToporsianMLamCSoluble endoglin contributes to the pathogenesis of preeclampsiaNat Med200612664264916751767
   PubMed Web of Science ®Google Scholar
• ConleyBAKolevaRSmithJDEndoglin controls cell migration and composition of focal adhesions: function of the cytosolic domainJ Biol Chem200427926274402744915084601
   PubMed Web of Science ®Google Scholar
• Sanz-RodriguezFGuerrero-EsteoMBotellaLMBanvilleDVaryCPBernabeuCEndoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteinsJ Biol Chem200427931328583286815148318
   PubMed Web of Science ®Google Scholar
• BourdeauADumontDJLetarteMA murine model of hereditary hemorrhagic telangiectasiaJ Clin Invest1999104101343135110562296
   PubMed Web of Science ®Google Scholar
• GougosASt JacquesSGreavesAIdentification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblastsInt Immunol19924183921371694
   PubMed Web of Science ®Google Scholar
• AdamPJCleshamGJWeissbergPLExpression of endoglin mRNA and protein in human vascular smooth muscle cellsBiochem Biophys Res Commun1998247133379636649
   PubMed Web of Science ®Google Scholar
• MachadoRDAldredMAJamesVMutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionHum Mutat200627212113216429395
   PubMed Web of Science ®Google Scholar
• LebrinFGoumansMJJonkerLEndoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transductionEMBO J200423204018402815385967
   PubMed Web of Science ®Google Scholar
• LebrinFDeckersMBertolinoPTen DijkePTGF-beta receptor function in the endotheliumCardiovasc Res200565359960815664386
   PubMed Web of Science ®Google Scholar
• LiCHampsonINHampsonLKumarPBernabeuCKumarSCD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cellsFASEB J2000141556410627280
   PubMed Web of Science ®Google Scholar
• Pece-BarbaraNVeraSKathirkamathambyKEndoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathwayJ Biol Chem200528030278002780815923183
   PubMed Web of Science ®Google Scholar
• ToporsianMGrosRKabirMGA role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasiaCirc Res200596668469215718503
   PubMed Web of Science ®Google Scholar
• JerkicMRivas-ElenaJVSantibanezJFEndoglin regulates cyclooxygenase-2 expression and activityCirc Res200699324825616840721
   PubMed Web of Science ®Google Scholar
• DochertyNGLopez-NovoaJMArevaloMEndoglin regulates renal ischaemia-reperfusion injuryNephrol Dial Transplant20062182106211916751653
   PubMed Web of Science ®Google Scholar
• ChenCZLiMde GraafDIdentification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cellsProc Natl Acad Sci USA20029924154681547312438646
   PubMed Web of Science ®Google Scholar
• ChoSKBourdeauALetarteMZuniga-PfluckerJCExpression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursorsBlood200198133635364211739167
   PubMed Web of Science ®Google Scholar
• BorgesLIacovinoMMayerhoferTA critical role for endoglin in the emergence of blood during embryonic developmentBlood2012119235417542822535663
   PubMed Web of Science ®Google Scholar
• QuRSilverMMLetarteMDistribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesen-chyme during valve formationCell Tissue Res199829223333439560476
   PubMed Web of Science ®Google Scholar
• MolinDGBartramUVan der HeidenKExpression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeletonDev Dyn2003227343144412815630
   PubMed Web of Science ®Google Scholar
• Nomura-KitabayashiAAndersonGASleepGEndoglin is dispensable for angiogenesis, but required for endocardial cushion formation in the midgestation mouse embryoDev Biol20093351667719703439
   PubMed Web of Science ®Google Scholar
• SridurongritSLarssonJSchwartzRRuiz-LozanoPKaartinenVSignaling via the Tgf-beta type I receptor Alk5 in heart developmentDev Biol2008322120821818718461
   PubMed Web of Science ®Google Scholar
• WootenECIyerLKMontefuscoMCApplication of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valvePLoS One201051e883020098615
   PubMed Web of Science ®Google Scholar
• RiusCSmithJDAlmendroNCloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1Blood19989212467746909845534
   PubMed Web of Science ®Google Scholar
• BotellaLMSanchez-ElsnerTRiusCCorbiABernabeuCIdentification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulationJ Biol Chem200127637344863449411432852
   PubMed Web of Science ®Google Scholar
• LiDChenHMehtaJLAngiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cellsHypertension20013851062106711711498
   PubMed Web of Science ®Google Scholar
• ChenKMehtaJLLiDJosephLJosephJTransforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin IICirc Res200495121167117315539634
   PubMed Web of Science ®Google Scholar
• Sanchez-ElsnerTBotellaLMVelascoBLangaCBernabeuCEndoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathwaysJ Biol Chem200227746437994380812228247
   PubMed Web of Science ®Google Scholar
• PospisilovaNSemeckyVJamborovaGEndoglin expression in hyper-cholesterolemia and after atorvastatin treatment in apoE-deficient miceJ Pharm Pharm Sci20069338839717207421
   PubMed Web of Science ®Google Scholar
• FernandezLAGarrido-MartinEMSanz-RodriguezFTherapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cellsThromb Haemost200797225426217264955
   PubMed Web of Science ®Google Scholar
• PrietoMRodriguez-PenaAArevaloMEffect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reductionKidney Blood Press Res2005281324015475654
   PubMed Web of Science ®Google Scholar
• ShyuKGWangBWChenWJKuanPHungCRMechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblastsEur J Heart Fail201012321922620156938
   PubMed Web of Science ®Google Scholar
• ChungYCHouYCPanACEndoglin (CD105) expression in the development of haemorrhoidsEur J Clin Invest200434210711214764073
   PubMed Web of Science ®Google Scholar
• ShyuKGWangBWWuGJLinCMChangHMechanical stretch via transforming growth factor-beta1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblastsEur J Heart Fail2013151364522941949
   PubMed Web of Science ®Google Scholar
• DakeishiMShioyaTWadaYGenetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of JapanHum Mutat200219214014811793473
   PubMed Web of Science ®Google Scholar
• KjeldsenADVasePGreenAHereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patientsJ Intern Med19992451313910095814
   PubMed Web of Science ®Google Scholar
• PorteousMEBurnJProctorSJHereditary haemorrhagic telangiectasia: a clinical analysisJ Med Genet19922985275301518020
   PubMed Web of Science ®Google Scholar
• WestermannCJRosinaAFDe VriesVde CoteauPAThe prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screeningAm J Med Genet A2003116A432432812522784
   PubMed Web of Science ®Google Scholar
• FerenceBAShannonTMWhiteRIJrZawinMBurdgeCMLife-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasiaChest19941065138713907956388
   PubMed Web of Science ®Google Scholar
• SabbaCPasculliGCirulliAHereditary hemorrhagic teleangiectasia (Rendu-Osler-Weber disease)Minerva Cardioangiol200250322123812107402
   PubMedGoogle Scholar
• ShovlinCLGuttmacherAEBuscariniEDiagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)Am J Med Genet2000911666710751092
   PubMed Web of Science ®Google Scholar
• TrembathRCThomsonJRMachadoRDClinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasiaN Engl J Med2001345532533411484689
   PubMed Web of Science ®Google Scholar
• FaughnanMEPaldaVAGarcia-TsaoGInternational guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasiaJ Med Genet2011482738719553198
   PubMed Web of Science ®Google Scholar
• AbdallaSALetarteMHereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of diseaseJ Med Genet20064329711015879500
   PubMed Web of Science ®Google Scholar
• Bayrak-ToydemirPMcDonaldJAkarsuNA fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7Am J Med Genet A2006140202155216216969873
   PubMed Web of Science ®Google Scholar
• ColeSGBegbieMEWallaceGMShovlinCLA new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5J Med Genet200542757758215994879
   PubMed Web of Science ®Google Scholar
• BourdeauACymermanUPaquetMEEndoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1Am J Pathol2000156391192310702408
   PubMed Web of Science ®Google Scholar
• SrinivasanSHanesMADickensTA mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2Hum Mol Genet200312547348212588795
   PubMed Web of Science ®Google Scholar
• CottinVDupuis-GirodSLescaGCordierJFPulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler disease)Respiration200774436137817641482
   PubMed Web of Science ®Google Scholar
• GirerdBMontaniDCouletFClinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationAm J Respir Crit Care Med2010181885186120056902
   PubMed Web of Science ®Google Scholar
• SimonneauGRobbinsIMBeghettiMUpdated clinical classification of pulmonary hypertensionJ Am Coll Cardiol200954Suppl 1S43S5419555858
   PubMed Web of Science ®Google Scholar
• JerkicMKabirMGDaviesAPulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stressCardiovasc Res201192337538421859819
   PubMed Web of Science ®Google Scholar
• ToporsianMJerkicMZhouYQSpontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasiaArterioscler Thromb Vasc Biol201030350951720042709
   PubMed Web of Science ®Google Scholar
• MahmoudMBorthwickGMHislopAAArthurHMEndoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAHLab Invest2009891152519015642
   PubMed Web of Science ®Google Scholar
• MacheCJGamillschegAPopperHHHaworthSGEarly-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1Thorax2008631858618156574
   PubMed Web of Science ®Google Scholar
• AlbinanaVBernabeu-HerreroMEZarrabeitiaRBernabeuCBotellaLMEstrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene on Endoglin and ALK1 expression in endothelial cellsThromb Haemost2010103352553420135064
   PubMed Web of Science ®Google Scholar
• van CutsemERutgeertsPVantrappenGTreatment of bleeding gastrointestinal vascular malformations with oestrogen-progesteroneLancet199033586959539551970032
   PubMed Web of Science ®Google Scholar
• YanivEPreisMShevroJNagerisBHadarTAnti-estrogen therapy for hereditary hemorrhagic telangiectasia – a long-term clinical trialRhinology201149221421621743879
   PubMed Web of Science ®Google Scholar
• ShovlinCLSulaimanNLGovaniFSJacksonJEBegbieMEElevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolismThromb Haemost20079851031103918000608
   PubMed Web of Science ®Google Scholar
• BowcockSJPatrickHELenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?Br J Haematol2009146222022219438503
   PubMed Web of Science ®Google Scholar
• KarnezisTTDavidsonTMEfficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxisLaryngoscope2011121363663821344445
   PubMed Web of Science ®Google Scholar
• LebrinFSrunSRaymondKThalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasiaNat Med201016442042820364125
   PubMed Web of Science ®Google Scholar
• SimondsJMillerFMandelJDavidsonTMThe effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasiaLaryngoscope2009119598899219194865
   PubMed Web of Science ®Google Scholar
• Dupuis-GirodSGinonISaurinJCBevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac outputJAMA2012307994895522396517
   PubMed Web of Science ®Google Scholar
• MitchellAAdamsLAMacQuillanGTibballsJvan den DriesenRDelriviereLBevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasiaLiver Transpl200814221021318236396
   PubMed Web of Science ®Google Scholar
• HighKAThe gene therapy journey for hemophilia: are we there yet?Blood2012120234482444822829631
   PubMed Web of Science ®Google Scholar
• MaguireAMSimonelliFPierceEASafety and efficacy of gene transfer for Leber’s congenital amaurosisN Engl J Med2008358212240224818441370
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Practice Bulletins–ObstetricsACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, Jan 2002Obstet Gynecol200299115916716175681
   PubMed Web of Science ®Google Scholar
• HutcheonJALisonkovaSJosephKSEpidemiology of pre-eclampsia and the other hypertensive disorders of pregnancyBest Pract Res Clin Obstet Gynaecol201125439140321333604
   PubMed Web of Science ®Google Scholar
• MacKayAPBergCJAtrashHKPregnancy-related mortality from preeclampsia and eclampsiaObstet Gynecol200197453353811275024
   PubMed Web of Science ®Google Scholar
• MaynardSEKarumanchiSAAngiogenic factors and preeclampsiaSemin Nephrol2011311334621266263
   PubMed Web of Science ®Google Scholar
• BellamyLCasasJPHingoraniADWilliamsDJPre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ2007335762797417975258
   PubMed Web of Science ®Google Scholar
• OdegardRAVattenLJNilsenSTSalvesenKAAustgulenRRisk factors and clinical manifestations of pre-eclampsiaBJOG2000107111410141611117771
   PubMed Web of Science ®Google Scholar
• SibaiBMRamadanMKUstaISalamaMMercerBMFriedmanSAMaternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)Am J Obstet Gynecol19931694100010068238109
   PubMed Web of Science ®Google Scholar
• DuckittKHarringtonDRisk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ2005330749156515743856
   PubMed Web of Science ®Google Scholar
• RedmanCWPlatelets and the beginnings of preeclampsiaN Engl J Med199032374784802374568
   PubMed Web of Science ®Google Scholar
• MeekinsJWPijnenborgRHanssensMMcFadyenIRvan AssheAA study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnanciesBr J Obstet Gynaecol199410186696747947500
   PubMedGoogle Scholar
• ZhouYDamskyCHFisherSJPreeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?J Clin Invest1997999215221649151787
   PubMed Web of Science ®Google Scholar
• ZhouYFisherSJJanatpourMHuman cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?J Clin Invest1997999213921519151786
   PubMed Web of Science ®Google Scholar
• SalafiaCMPezzulloJCGhidiniALopez-ZenoJAWhittingtonSSClinical correlations of patterns of placental pathology in preterm pre-eclampsiaPlacenta199819167729481787
   PubMed Web of Science ®Google Scholar
• AhmadSAhmedAElevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsiaCirc Res200495988489115472115
   PubMed Web of Science ®Google Scholar
• MaynardSEMinJYMerchanJExcess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJ Clin Invest2003111564965812618519
   PubMed Web of Science ®Google Scholar
• GilbertJSRyanMJLaMarcaBBSedeekMMurphySRGrangerJPPathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunctionAm J Physiol Heart Circ Physiol20082942H541H55018055511
   PubMed Web of Science ®Google Scholar
• KendallRLThomasKAInhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptorProc Natl Acad Sci USA1993902210705107098248162
   PubMed Web of Science ®Google Scholar
• KapurNKHeffernanKSYunisAAElevated soluble fms-like tyrosine kinase-1 levels in acute coronary occlusionArterioscler Thromb Vasc Biol201131244345021071694
   PubMed Web of Science ®Google Scholar
• ClarkDESmithSKHeYA vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulationBiol Reprod1998596154015489828203
   PubMed Web of Science ®Google Scholar
• LevineRJLamCQianCSoluble endoglin and other circulating antiangiogenic factors in preeclampsiaN Engl J Med200635510992100516957146
   PubMed Web of Science ®Google Scholar
• LevineRJMaynardSEQianCCirculating angiogenic factors and the risk of preeclampsiaN Engl J Med2004350767268314764923
   PubMed Web of Science ®Google Scholar
• Valbuena-DiezACBlancoFJOujoBOxysterol-induced soluble endoglin release and its involvement in hypertensionCirculation2012126222612262423110859
   PubMed Web of Science ®Google Scholar
• JerkicMRivas-ElenaJVPrietoMEndoglin regulates nitric oxide-dependent vasodilatationFASEB J200418360961114734648
   PubMedGoogle Scholar
• Lopez-NovoaJMBernabeuCThe physiological role of endoglin in the cardiovascular systemAm J Physiol Heart Circ Physiol20102994H959H97420656886
   PubMed Web of Science ®Google Scholar
• GuYLewisDFWangYPlacental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnanciesJ Clin Endocrinol Metab200893126026617956952
   PubMed Web of Science ®Google Scholar
• GilbertJSGilbertSAAranyMGrangerJPHypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expressionHypertension200953239940319075097
   PubMed Web of Science ®Google Scholar
• CudmoreMAhmadSAl-AniBNegative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1Circulation2007115131789179717389265
   PubMed Web of Science ®Google Scholar
• BergmannAAhmadSCudmoreMReduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse modelJ Cell Mol Med2010146B1857186719538465
   PubMed Web of Science ®Google Scholar
• LiZZhangYYing MaJRecombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsiaHypertension200750468669217724276
   PubMed Web of Science ®Google Scholar
• SuzukiHOhkuchiAMatsubaraSEffect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant miceHypertension20095451129113519786649
   PubMed Web of Science ®Google Scholar
• ThadhaniRKisnerTHagmannHPilot study of extracorpo-real removal of soluble fms-like tyrosine kinase 1 in preeclampsiaCirculation2011124894095021810665
   PubMed Web of Science ®Google Scholar
• GeorgeEMCockrellKAranayMCsongradiEStecDEGrangerJPInduction of heme oxygenase 1 attenuates placental ischemia-induced hypertensionHypertension201157594194821383306
   PubMed Web of Science ®Google Scholar
• DevyLHuangLNaaLSelective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesisCancer Res20096941517152619208838
   PubMed Web of Science ®Google Scholar
• OverallCMKleifeldOTumour microenvironment – opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNat Rev Cancer20066322723916498445
   PubMed Web of Science ®Google Scholar
• CowieMRMosterdAWoodDAThe epidemiology of heart failureEur Heart J19971822082259043837
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDAdamsRCarnethonMHeart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation20091193e21e18119075105
   PubMed Web of Science ®Google Scholar
• BerkBCFujiwaraKLehouxSECM remodeling in hypertensive heart diseaseJ Clin Invest2007117356857517332884
   PubMed Web of Science ®Google Scholar
• LeaskATGFbeta, cardiac fibroblasts, and the fibrotic responseCardiovasc Res200774220721216919613
   PubMed Web of Science ®Google Scholar
• RitzenthalerJDGoldsteinRHFineASmithBDRegulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation elementJ Biol Chem19932681813625136318514794
   PubMed Web of Science ®Google Scholar
• QiaoBPadillaSRBenyaPDTransforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signalingJ Biol Chem200528017175621757115743758
   PubMed Web of Science ®Google Scholar
• LeaskAHolmesABlackCMAbrahamDJConnective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblastsJ Biol Chem200327815130081301512571253
   PubMed Web of Science ®Google Scholar
• ChenMMLamAAbrahamJASchreinerGFJolyAHCTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosisJ Mol Cell Cardiol200032101805181911013125
   PubMed Web of Science ®Google Scholar
• Chuva de Sousa LopesSMFeijenAKorvingJConnective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarctionDev Dyn2004231354255015376321
   PubMed Web of Science ®Google Scholar
• FrantzSHuKAdamekATransforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarctionBasic Res Cardiol2008103548549218651091
   PubMed Web of Science ®Google Scholar
• KuwaharaFKaiHTokudaKTransforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded ratsCirculation2002106113013512093782
   PubMed Web of Science ®Google Scholar
• KapurNKHeffernanKSYunisAAUsefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failureAm J Cardiol2010106121770177621126621
   PubMed Web of Science ®Google Scholar
• YanavitskiMGivertzMMNovel biomarkers in acute heart failureCurr Heart Fail Rep20118320621121681444
   PubMedGoogle Scholar
• PetersonJTLiHDillonLBryantJWEvolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted ratCardiovasc Res200046230731510773235
   PubMed Web of Science ®Google Scholar
• ZeisbergMHanaiJSugimotoHBMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injuryNat Med20039796496812808448
   PubMed Web of Science ®Google Scholar
• Cruz-GonzalezIPabonPRodriguez-BarberoAIdentification of serum endoglin as a novel prognostic marker after acute myocardial infarctionJ Cell Mol Med200812395596118494936
   PubMed Web of Science ®Google Scholar
• KapurNKShenoyCYunisAADistinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptidesPLoS One201274e3434422509290
   PubMed Web of Science ®Google Scholar
• NachtigalPZemankova VecerovaLRathouskaJStraskyZThe role of endoglin in atherosclerosisAtherosclerosis2012224141122460049
   PubMed Web of Science ®Google Scholar